SAGAseq - ultrasensitive cancer liquid biopsy sequencing

20M kr SEK

Funder	Vinnova
Recipient Organization	Saga Diagnostics Ab
Country	Sweden
Start Date	Mar 11, 2021
End Date	Dec 31, 2022
Duration	660 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2020-04949_Vinnova`

Grant Description

Purpose and goal:

Aim: develop ultrasensitive and cancer-specific panels in order to improve monitoring. Fulfilment: An ultrasensitive combination product. Expected results and effects:

Our method can be used to track MRD and find relapses in different cancer types. This has created a big interest among KOLs. Approach and implementation:

Plan vs reality: Our execution suffered due to Covid, moreover the market needs changed during the course of the project which led to pivoting.